-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Capricor Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2015 to Q4 2024.
- Capricor Therapeutics, Inc. Depreciation for the quarter ending December 31, 2024 was $376K, a 22.1% increase year-over-year.
- Capricor Therapeutics, Inc. Depreciation for the twelve months ending December 31, 2024 was $1.43M, a 33.3% increase year-over-year.
- Capricor Therapeutics, Inc. annual Depreciation for 2024 was $1.43M, a 33.3% increase from 2023.
- Capricor Therapeutics, Inc. annual Depreciation for 2023 was $1.07M, a 100% increase from 2022.
- Capricor Therapeutics, Inc. annual Depreciation for 2022 was $533K, a 119% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)